Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. (Q40041720)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

mumps virus

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Shigefumi Okamoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Pranee Somboonthum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Hironori Yoshii

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Yasuyuki Gomi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Yasuo Uchiyama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Michiaki Takahashi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Koichi Yamanishi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Yasuko Mori

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

5 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

8741-8755

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

Live attenuated varicella vaccine

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Update on varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

The varicella vaccine. Vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Varicella-zoster virus as a live vector for the expression of foreign genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Mumps vaccine virus strains and aseptic meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance centres and by Pasteur-Mérieux Sérums & Vaccins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Mumps vaccine complications: which strain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Mumps resurgence in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Polypeptides of Varicella-Zoster Virus (VZV) and Immunological Relationship of VZV and Herpes Simplex Virus (HSV)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

An efficient method for precise gene substitution in the AcMNPV genome by homologous recombination in E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

A technique for ultracryotomy of cell suspensions and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Experimental Infection of Guinea Pigs with Varicella-Zoster Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Varicella-zoster virus specifies a thymidylate synthetase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Stability of a varicella-zoster virus glycoprotein E epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Cell-specific effects of human cytomegalovirus unique region on recombinant protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3'-untranslated sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

The role of the trans-Golgi network in varicella zoster virus biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Adverse events associated with MMR vaccines in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.10.039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18053621%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference